Mark Erlander

CRDF

Mark Erlander serves as Chief Executive Officer at Cardiff Oncology, Inc. (CRDF). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$24.3K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$24.3K

Companies Traded

CRDF

Active Period

Mar 2021 – Nov 2022

2 total trades

Most Recent

Buy CRDF

Nov 25, 2022 · $14.3K

Mark Erlander's Insider Trading at Cardiff Oncology, Inc. (CRDF)

Buys

2 · $24.3K

Sells

0 · $0.00

Total Shares Bought

10,965

Total Shares Sold

CRDF Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Nov 25, 2022	Buy	10,000	$1.43	$14.3K	0
Mar 23, 2021	Buy	965	$10.34	$10.0K	0

Related Insiders

Mani Mohindru

director, officer: Chief Executive Officer

CRDFBuy · Jun 22, 2026

PACE GARY W

Director

CRDFBuy · Jun 22, 2026

Explore More Insider Trading Data

CRDF Insider Trading Activity

View all insider trades at Cardiff Oncology, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity